KFI
NBIX icon

Key Financial Inc’s Neurocrine Biosciences NBIX Stock Holding History

Key Financial Inc’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.73K Hold
34
– – ﹤0.01% 991
2026
Q1 		$4.48K Hold
34
– – ﹤0.01% 1053
2025
Q4 		$4.82K Hold
34
– – ﹤0.01% 1040
2025
Q3 		$4.66K Hold
34
– – ﹤0.01% 1056
2025
Q2 		$4.27K Hold
34
– – ﹤0.01% 1068
2025
Q1 		$3.76K Hold
34
– – ﹤0.01% 1056
2024
Q4 		$4.64K Hold
34
– – ﹤0.01% 1014
2024
Q3 		$3.92K Hold
34
– – ﹤0.01% 1024
2024
Q2 		$4.68K Hold
34
– – ﹤0.01% 974
2024
Q1 		$4.69K Hold
34
– – ﹤0.01% 956
2023
Q4 		$4.48K Hold
34
– – ﹤0.01% 964
2023
Q3 		$3.83K Hold
34
– – ﹤0.01% 1003
2023
Q2 		$3.21K Buy
+34
New +$3.32K ﹤0.01% 1094

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Key Financial Inc's NBIX Position: Q2 2026 in Review

Key Financial Inc held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 34 shares worth $5.73K. The position accounts for ﹤0.01% of the portfolio, ranked #991.

Key Financial Inc first reported a position in NBIX in Q2 2023 and has held it in 13 quarters since. 779 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Key Financial Inc held 34 shares of Neurocrine Biosciences worth $5.73K as of Q2 2026.
  • Key Financial Inc left its Neurocrine Biosciences share count unchanged in Q2 2026.
  • Neurocrine Biosciences made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #991 holding.
  • Key Financial Inc first reported a position in Neurocrine Biosciences in Q2 2023 and has held it in 13 quarters since.
  • 779 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.